Home > Products > InVivoPro

InVivoPro Anti-Mouse PD-L1(B7-H1, CD274) in vivo antibody, Clone 10F.9G2

Catalog: IV0101
Cost advantage to: BE0101
Clone: 10F.9G2
Isotype: Rat IgG2b κ
Citations of the same Clone: 483
Product Details Specifications Application References Related Products

Product Details

CD274, also known as B7-H1 and PD-L1, is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. It is expressed on T cells, B cells, NK cells, dendritic cells, IFN-γ activated endothelial cells, and monocytes.

Specifications

Catalog IV0101
Product Name InVivoPro Anti-Mouse PD-L1(B7-H1, CD274) in vivo antibody, Clone 10F.9G2
Size 1mg/5mg/25mg/50mg/100mg
Isotype Rat IgG2b κ
Clone 10F.9G2
Target PD-L1
Other Names Programmed cell death ligand 1,B7-H1,CD274,PD-L1
Isotype Control Catalog Code IV0106 or Rat IgG2b Isotype Control 
Dilution Buffer PBS, pH 7.2, contains no stabilizers or preservatives
Reactivity Mouse
Host Species Rat
How much antibody to use in vivo 200-500 μg per mouse; or 10 mg/kg. This range is based off the most recent publication data using the 10F.9G2 clone in vivo. Each investigator should  determine their own optimal working dilution for specific applications.
Background(ichorbio) CD274, also known as B7-H1 and PD-L1, is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. It is expressed on T cells, B cells, NK cells, dendritic cells, IFN-γ activated endothelial cells, and monocytes.
Applications In vivo PD-L1 blocked
Purification protein A or G
Storage This antibody is stable for at least 2 months when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at -20°C or -80°C. Avoid repeated freeze thaw cycles.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS Buffer, PH 7.2, with no carrier protein, or preservatives.
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg, by the LAL method
Purity 99%

Application References

Spitzer, Matthew H., et al. "Systemic immunity is required for effective cancer immunotherapy." Cell 168.3 (2017): 487-502.

Poggio, Mauro, et al. "Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory." Cell 177.2 (2019): 414-427.

Balood, Mohammad, et al. "Nociceptor neurons affect cancer immunosurveillance." Nature 611.7935 (2022): 405-412.

Related Products